Today

Agents

Chat

Arena

Discover

More

App

Entera Bio appoints Juan Camilo Arjona Ferreira to board effective Dec. 1 - ENTX News | Rallies

Entera Bio appoints Juan Camilo Arjona Ferreira to board effective Dec. 1

ENTX•2026-10-27

Entera Bio appointed Juan Camilo Arjona Ferreira to its board, effective Dec. 1, 2026. He will succeed Haya Taitel, who is stepping down.

1. Board appointment

Arjona Ferreira is Organon's head of research and development and chief medical officer, with more than 20 years of clinical development experience.

Related News

US research roundup: Clearwater Paper, Molina Healthcare, Qualys

CLW•2026-10-27

Moelis names David Pett managing director for family office coverage

MC•2026-10-27

SecureTech forms joint venture with QSTAK to tokenize real-world assets

Sources

S

Entera Bio appoints Juan Camilo Arjona Ferreira to board effective Dec. 1

Sec

2026-10-27

AIAI Holdings says M42 projects agreement to generate about $125 million in cash in 2027

AIAI•2026-10-27

Grandstand publishes update to financial calendar

GRSD•2026-10-27